Insulin Infusion Systems
"Insulin Infusion Systems" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Portable or implantable devices for infusion of insulin. Includes open-loop systems which may be patient-operated or controlled by a pre-set program and are designed for constant delivery of small quantities of insulin, increased during food ingestion, and closed-loop systems which deliver quantities of insulin automatically based on an electronic glucose sensor.
Descriptor ID |
D007332
|
MeSH Number(s) |
E02.319.300.508 E07.505.508 E07.858.082.505.508
|
Concept/Terms |
Insulin Infusion Systems- Insulin Infusion Systems
- Infusion System, Insulin
- Infusion Systems, Insulin
- Insulin Infusion System
- System, Insulin Infusion
- Systems, Insulin Infusion
Implantable Programmable Insulin Pump- Implantable Programmable Insulin Pump
- Programmable Implantable Insulin Pump
- Pump, Programmable Implantable Insulin
- Insulin Pump, Programmable Implantable
beta Cell, Artificial- beta Cell, Artificial
- Artificial beta Cell
- Artificial beta Cells
- Cell, Artificial beta
- Cells, Artificial beta
- beta Cells, Artificial
|
Below are MeSH descriptors whose meaning is more general than "Insulin Infusion Systems".
Below are MeSH descriptors whose meaning is more specific than "Insulin Infusion Systems".
This graph shows the total number of publications written about "Insulin Infusion Systems" by people in this website by year, and whether "Insulin Infusion Systems" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2000 | 1 | 0 | 1 | 2003 | 0 | 1 | 1 | 2004 | 2 | 0 | 2 | 2005 | 1 | 0 | 1 | 2007 | 1 | 0 | 1 | 2008 | 1 | 1 | 2 | 2009 | 3 | 2 | 5 | 2010 | 2 | 2 | 4 | 2011 | 1 | 0 | 1 | 2012 | 2 | 2 | 4 | 2013 | 4 | 2 | 6 | 2014 | 3 | 3 | 6 | 2015 | 5 | 3 | 8 | 2016 | 4 | 3 | 7 | 2017 | 8 | 9 | 17 | 2018 | 12 | 6 | 18 | 2019 | 8 | 8 | 16 | 2020 | 12 | 11 | 23 | 2021 | 4 | 12 | 16 | 2022 | 2 | 17 | 19 | 2023 | 1 | 7 | 8 | 2024 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Insulin Infusion Systems" by people in Profiles.
-
Hood KK, Schneider-Utaka AK, Reed ZW, Buckingham BA, Cobry E, DeBoer MD, Ekhlaspour L, Schoelwer M, Paul Wadwa R, Lum J, Kollman C, Beck RW, Breton MD. Patient reported outcomes (PROs) and user experiences of young children with type 1 diabetes using t:slim X2 insulin pump with control-IQ technology. Diabetes Res Clin Pract. 2024 Feb; 208:111114.
-
Criego AB, Carlson AL, Brown SA, Forlenza GP, Bode BW, Levy CJ, Hansen DW, Hirsch IB, Bergenstal RM, Sherr JL, Mehta SN, Laffel LM, Shah VN, Bhargava A, Weinstock RS, MacLeish SA, DeSalvo DJ, Jones TC, Aleppo G, Buckingham BA, Ly TT. Two Years with a Tubeless Automated Insulin Delivery System: A Single-Arm Multicenter Trial in Children, Adolescents, and Adults with Type 1 Diabetes. Diabetes Technol Ther. 2024 Jan; 26(1):11-23.
-
Pihoker C, Shulman DI, Forlenza GP, Kaiserman KB, Sherr JL, Thrasher JR, Buckingham BA, Kipnes MS, Bode BW, Carlson AL, Lee SW, Latif K, Liljenquist DR, Slover RH, Dai Z, Niu F, Shin J, Jonkers RAM, Roy A, Grosman B, Vella M, Cordero TL, McVean J, Rhinehart AS, Vigersky RA. Safety and Glycemic Outcomes During the MiniMedTM Advanced Hybrid Closed-Loop System Pivotal Trial in Children and Adolescents with Type 1 Diabetes. Diabetes Technol Ther. 2023 11; 25(11):755-764.
-
Akturk HK, McKee AM. Emerging Technologies and Therapeutics for Type 1 Diabetes. Endocrinol Metab Clin North Am. 2024 Mar; 53(1):81-91.
-
Cordero TL, Dai Z, Arrieta A, Niu F, Vella M, Shin J, Rhinehart AS, McVean J, Lee SW, Slover RH, Forlenza GP, Shulman DI, Pop-Busui R, Thrasher JR, Kipnes MS, Christiansen MP, Buckingham BA, Pihoker C, Sherr JL, Kaiserman KB, Vigersky RA. Glycemic Outcomes During Early Use of the MiniMed? 780G Advanced Hybrid Closed-Loop System with Guardian? 4 Sensor. Diabetes Technol Ther. 2023 09; 25(9):652-658.
-
Alonso GT, Triolo TM, Akturk HK, Pauley ME, Sobczak M, Forlenza GP, Sakamoto C, Pyle L, Frohnert BI. Increased Technology Use Associated With Lower A1C in a Large Pediatric Clinical Population. Diabetes Care. 2023 06 01; 46(6):1218-1222.
-
Beck RW, Kanapka LG, Breton MD, Brown SA, Wadwa RP, Buckingham BA, Kollman C, Kovatchev B. A Meta-Analysis of Randomized Trial Outcomes for the t:slim X2 Insulin Pump with Control-IQ Technology in Youth and Adults from Age 2 to 72. Diabetes Technol Ther. 2023 05; 25(5):329-342.
-
Wadwa RP, Reed ZW, Buckingham BA, DeBoer MD, Ekhlaspour L, Forlenza GP, Schoelwer M, Lum J, Kollman C, Beck RW, Breton MD. Trial of Hybrid Closed-Loop Control in Young Children with Type 1 Diabetes. N Engl J Med. 2023 Mar 16; 388(11):991-1001.
-
Szmuilowicz ED, Levy CJ, Buschur EO, Polsky S. Expert Guidance on Off-Label Use of Hybrid Closed-Loop Therapy in Pregnancies Complicated by Diabetes. Diabetes Technol Ther. 2023 05; 25(5):363-373.
-
Garg SK, Grunberger G, Weinstock R, Lawson ML, Hirsch IB, DiMeglio LA, Pop-Busui R, Philis-Tsimikas A, Kipnes M, Liljenquist DR, Brazg RL, Kudva YC, Buckingham BA, McGill JB, Carlson AL, Criego AB, Christiansen MP, Kaiserman KB, Griffin KJ, Forlenza GP, Bode BW, Slover RH, Keiter A, Ling C, Marinos B, Cordero TL, Shin J, Lee SW, Rhinehart AS, Vigersky RA. Improved Glycemia with Hybrid Closed-Loop Versus Continuous Subcutaneous Insulin Infusion Therapy: Results from a Randomized Controlled Trial. Diabetes Technol Ther. 2023 01; 25(1):1-12.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|